[Cancer research: a privileged field of investigation on chance, reductionism and holism].

Med Sci (Paris)

Institut Cochin, université Paris Descartes, CNRS (UMR 8104), Paris, France - Inserm, U1016, Paris, France.

Published: September 2014

The debate between reductionism and anti-reductionism, dealing with the ultimate constituents of the world, is one of the fundamental issues in the philosophy of science. However, in biology, reductionism is less of an ontological and more of an epistemological question: it argues that the explanation of biological processes resides in deciphering the genetic code of living entities. This position is still prevalent in cancer biology, which has long been defined as a cellular process where genetic alterations are responsible for aberrant proliferation. While the hypothesis of somatic mutations remains the central theoretical model, a bundle of experimental data reveals how important the disturbances of tissue organisation are in cancer development, leading to a renewal of holistic and organicist approaches. This latter perspective in particular attempts to contextualise and rethink the centrality of the genetic level by proposing a new conception of cancerogenesis as a tissue disease.

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20143006019DOI Listing

Publication Analysis

Top Keywords

[cancer privileged
4
privileged field
4
field investigation
4
investigation chance
4
chance reductionism
4
reductionism holism]
4
holism] debate
4
debate reductionism
4
reductionism anti-reductionism
4
anti-reductionism dealing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!